Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 38.73%680.01M | 42.96%406.13M | 21.55%158.66M | -30.45%750.65M | -28.10%490.17M | -42.26%284.08M | -53.40%130.53M | 19.60%1.08B | 5.44%681.7M | 17.54%492M |
| Refunds of taxes and levies | -65.89%447.62K | -38.44%448.8K | 183.95%129.65K | 15.94%1.31M | 20.44%1.31M | --729.08K | 82.82%45.66K | -97.61%1.13M | -97.70%1.09M | ---- |
| Cash received relating to other operating activities | 5.72%151.79M | 63.15%167.93M | 487.23%162.61M | -33.79%150.38M | -33.37%143.58M | -39.47%102.93M | 17.73%27.69M | 17.66%227.11M | 416.51%215.48M | 693.18%170.06M |
| Cash inflows from operating activities | 31.05%832.25M | 48.17%574.51M | 103.07%321.4M | -30.99%902.34M | -29.30%635.06M | -41.43%387.74M | -47.88%158.27M | 14.42%1.31B | 22.12%898.27M | 35.87%662.05M |
| Goods services cash paid | 44.66%462.06M | 89.53%307.75M | 89.09%166.37M | -24.86%454.18M | -27.10%319.41M | -34.88%162.38M | -32.23%87.99M | -1.94%604.4M | -15.22%438.17M | -22.97%249.33M |
| Staff behalf paid | -15.26%72.61M | -9.12%51.7M | -29.53%21.4M | -34.49%93.42M | -13.69%85.69M | -21.03%56.89M | -24.59%30.36M | 19.64%142.61M | 4.39%99.28M | 8.34%72.04M |
| All taxes paid | 30.61%18.02M | 5.45%10.66M | 102.49%8.47M | -54.85%13.3M | -9.01%13.79M | -19.90%10.1M | -45.19%4.18M | 43.61%29.47M | 53.51%15.16M | 94.79%12.62M |
| Cash paid relating to other operating activities | -80.63%29.5M | -65.91%38.92M | -29.15%34.12M | -28.21%141.98M | -8.80%152.25M | -20.93%114.18M | -57.42%48.16M | -34.51%197.76M | 173.06%166.95M | 346.87%144.4M |
| Cash outflows from operating activities | 1.93%582.18M | 19.06%409.03M | 34.96%230.35M | -27.85%702.88M | -20.62%571.15M | -28.18%343.55M | -41.31%170.69M | -7.92%974.24M | 5.36%719.55M | 11.52%478.39M |
| Net cash flows from operating activities | 291.31%250.07M | 274.51%165.48M | 833.27%91.05M | -40.15%199.46M | -64.24%63.91M | -75.94%44.19M | -196.92%-12.42M | 293.29%333.26M | 239.59%178.72M | 215.13%183.67M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | --0 | ---- | --0 | -99.65%349.73K | -98.90%1.25M | -99.41%349.73K | --349.73K | 106,396.70%98.84M | 122,371.20%113.67M | 63,798.02%59.31M |
| Cash received from returns on investments | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | --184K | ---- | --0 | -99.86%626.68K | --0 | ---- | --0 | --444.18M | --1.55M | ---- |
| Net cash received from disposal of subsidiaries and other business units | --0 | ---- | --0 | -99.39%901.5K | --0 | ---- | --0 | 0.18%148.27M | ---- | ---- |
| Cash received relating to other investing activities | --0 | ---- | --0 | -58.46%5M | --0 | ---- | -98.25%21.47K | 27.51%12.04M | 85.38%11.86M | -66.37%1.55M |
| Cash inflows from investing activities | -85.25%184K | ---- | --0 | -99.02%6.88M | -99.02%1.25M | -99.43%349.73K | -69.75%371.21K | 344.78%703.33M | 1,691.69%127.08M | 1,196.73%60.85M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -56.56%5.32M | 142.06%3.03M | 267.57%2.08M | -56.32%2.02M | 184.60%12.26M | -58.20%1.25M | -78.21%565.72K | -51.78%4.62M | -40.74%4.31M | -44.82%3M |
| Cash paid to acquire investments | --13M | --13M | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- |
| Net cash paid to acquire subsidiaries and other business units | --0 | ---- | --13M | ---- | --0 | ---- | --0 | ---- | ---- | ---- |
| Impawned loan net increase | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- | ---- | ---- |
| Cash paid relating to other investing activities | --8.59M | --6.85M | --4.81M | ---- | --0 | ---- | --0 | 448.27%515.37K | 854.40%515.37K | --495.37K |
| Cash outflows from investing activities | 119.55%26.91M | 1,726.91%22.88M | 3,416.32%19.89M | -60.70%2.02M | 154.18%12.26M | -64.13%1.25M | -78.21%565.72K | -46.92%5.14M | -34.14%4.82M | -35.69%3.49M |
| Net cash flows from investing activities | -142.76%-26.73M | -2,434.71%-22.88M | -10,126.77%-19.89M | -99.30%4.86M | -109.00%-11.01M | -101.57%-902.71K | 85.79%-194.52K | 370.33%698.19M | 53,554.22%122.26M | 7,880.11%57.36M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- |
| Cash from borrowing | --0 | ---- | --0 | -76.74%10M | -88.08%5M | ---- | --0 | -41.11%42.99M | -53.91%41.94M | -70.31%21.08M |
| Cash received relating to other financing activities | -80.33%93M | -81.39%88M | --0 | 31,019.76%497.92M | --472.92M | --472.92M | --16.55M | -98.00%1.6M | ---- | ---- |
| Cash inflows from financing activities | -80.54%93M | -81.39%88M | --0 | 1,039.13%507.92M | 1,039.54%477.92M | 2,143.68%472.92M | 175.89%16.55M | -70.86%44.59M | -53.91%41.94M | -76.84%21.08M |
| Borrowing repayment | -79.71%97.71M | -82.09%83.21M | --0 | 74.94%552.52M | 258.12%481.55M | 288.93%464.64M | --11M | 140.39%315.83M | 17.85%134.47M | 4.70%119.47M |
| Dividend interest payment | -34.78%33.23M | -39.64%22.99M | -37.18%11.43M | -40.00%59.48M | -33.22%50.95M | -22.08%38.08M | -24.98%18.2M | -6.87%99.14M | -4.43%76.3M | -7.35%48.87M |
| -Including:Cash payments for dividends or profit to minority shareholders | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- |
| Cash payments relating to other financing activities | -8.45%228.01M | -52.28%86.7M | -96.56%4.26M | -55.76%263.44M | -11.16%249.06M | -31.99%181.7M | 61.13%123.78M | 194.29%595.41M | 2,456.22%280.35M | 3,218.05%267.15M |
| Cash outflows from financing activities | -54.07%358.95M | -71.82%192.9M | -89.74%15.69M | -13.36%875.44M | 59.14%781.57M | 57.16%684.43M | 51.35%152.98M | 129.55%1.01B | 139.67%491.11M | 148.99%435.49M |
| Net cash flows from financing activities | 12.42%-265.95M | 50.41%-104.9M | 88.50%-15.69M | 61.95%-367.52M | 32.40%-303.65M | 48.96%-211.51M | -43.49%-136.43M | -236.33%-965.8M | -294.32%-449.17M | -393.92%-414.41M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -100.49%-75.5 | -100.40%-62.56 | -100.11%-15.49 | 14.76%15.53K | -37.88%15.38K | -48.45%15.46K | 221.82%13.87K | -80.35%13.53K | -70.58%24.76K | -22.62%29.99K |
| Net increase in cash and cash equivalents | 83.01%-42.61M | 122.42%37.71M | 137.22%55.46M | -348.50%-163.19M | -69.22%-250.74M | 2.96%-168.21M | -78.15%-149.03M | 221.82%65.67M | -141.22%-148.18M | -558.68%-173.35M |
| Add:Begin period cash and cash equivalents | -55.14%132.7M | -55.14%132.7M | -54.74%133.86M | 28.54%295.78M | 28.54%295.78M | 28.54%295.78M | 28.54%295.78M | -18.98%230.12M | -18.98%230.12M | -18.98%230.12M |
| End period cash equivalent | 100.00%90.09M | 33.58%170.41M | 29.01%189.32M | -55.17%132.6M | -45.03%45.05M | 124.73%127.57M | 0.20%146.76M | 28.54%295.78M | -63.19%81.94M | -77.97%56.77M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Zhongxing Cai Guanghua Certified Public Accountants (Special General Partnership) | -- | -- | -- | ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.